Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund - DAFNA Capital Management

Nathan Fischel Bio, Returns, Net Worth

DAFNA Capital Management is founded by Nathan Fischel in January 1999. Nathan Fischel is an M.D. and manages the hedge fund with his wife Fariba Ghodsian who has a Ph.D. in Biomedical Engineering from Oxford University. DAFNA Capital makes fundamental and event-driven long and short bets in biotech and medical device companies.

Nathan Fischel
Fund Profile
Filing Period:
Fund Name: DAFNA Capital Management
Manager Nathan Fischel
Portfolio Value $143,580,000
Change This QTR +99.00%
Fund Holdings Sector Distribution
Filing Period:
Last update:
No. Security Ticker Shares Value (x$1000) Activity % Port
1.
Vitae Pharmaceuticals Inc
715,988 $14,978 10.43%
2.
Cynapsus Therapeutics Inc
230,201 $9,256 6.44%
3. ATRC 528,946 $8,368 5.82%
4. NXTM 238,509 $5,960 4.15%
5. TNDM 724,286 $5,548 3.86%
Latest 13D & 13G Filings
Company Symbol Filed By Filing Date Filing
2016-10-11
News, Interviews and Investor Letters